{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:03:15Z","timestamp":1788397395374,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K08-DK117013"],"award-info":[{"award-number":["K08-DK117013"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ajt.2023.03.008","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T22:11:20Z","timestamp":1679004680000},"page":"794-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The effectiveness and safety of antibody induction immunosuppression in a large cohort of United States pediatric liver transplant recipients"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-9622","authenticated-orcid":false,"given":"Phoebe","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1942-6197","authenticated-orcid":false,"given":"Yuan-Shung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3835-6400","authenticated-orcid":false,"given":"Lucia","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0142-2726","authenticated-orcid":false,"given":"Eimear","family":"Kitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8682-972X","authenticated-orcid":false,"given":"Peter L.","family":"Abt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8576-0193","authenticated-orcid":false,"given":"Therese","family":"Bittermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1016\/j.ajt.2023.03.008_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/ajt.16494","article-title":"OPTN\/SRTR 2019 annual data report: liver","volume":"21","author":"Kwong","year":"2021","journal-title":"Am J Transplant"},{"issue":"suppl","key":"10.1016\/j.ajt.2023.03.008_bib2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/ajt.15676","article-title":"OPTN\/SRTR 2018 annual data report: heart","volume":"20","author":"Colvin","year":"2020","journal-title":"Am J Transplant"},{"issue":"suppl","key":"10.1016\/j.ajt.2023.03.008_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ajt.15672","article-title":"OPTN\/SRTR 2018 annual data report: kidney","volume":"20","author":"Hart","year":"2020","journal-title":"Am J Transplant"},{"issue":"suppl","key":"10.1016\/j.ajt.2023.03.008_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/ajt.15677","article-title":"OPTN\/SRTR 2018 annual data report: lung","volume":"20","author":"Valapour","year":"2020","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2023.03.008_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1399-3046.2005.00303.x","article-title":"Anti-IL-2 receptor antibody vs. polyclonal anti-lymphocyte antibody as induction therapy in pediatric transplantation","volume":"9","author":"Di Filippo","year":"2005","journal-title":"Pediatr Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2023.03.008_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13573","article-title":"Analysis of rabbit anti-thymocyte globulin vs basiliximab induction in pediatric liver transplant recipients","volume":"23","author":"Newland","year":"2019","journal-title":"Pediatr Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2023.03.008_bib7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/petr.12362","article-title":"Interleukin-2 receptor antagonists for pediatric liver transplant recipients: a systematic review and meta-analysis of controlled studies","volume":"18","author":"Crins","year":"2014","journal-title":"Pediatr Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2023.03.008_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14077","article-title":"Induction and maintenance immunosuppression in pediatric kidney transplantation-advances and controversies","volume":"25","author":"Balani","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2023.03.008_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13873","article-title":"Variation in immunosuppression practices among pediatric liver transplant centers-Society of Pediatric Liver Transplantation survey results","volume":"25","author":"Slowik","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2023.03.008_bib10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/lt.26259","article-title":"Center variability in acute rejection and biliary complications after pediatric liver transplantation","volume":"28","author":"Kanneganti","year":"2022","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.ajt.2023.03.008_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13168","article-title":"Successful merging of data from the United Network for Organ Sharing and the Pediatric Health Information System databases","volume":"22","author":"Getz","year":"2018","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2023.03.008_bib12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1600-6143.2006.01674.x","article-title":"Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients\u2014an analysis of USRDS data","volume":"7","author":"Dharnidharka","year":"2007","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2023.03.008_bib13","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/cid\/ciy776","article-title":"Estimation of direct healthcare costs of fungal diseases in the United States","volume":"68","author":"Benedict","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ajt.2023.03.008_bib14","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3201\/eid2606.191570","article-title":"Cannabis use and fungal infections in a commercially insured population, United States, 2016","volume":"26","author":"Benedict","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.ajt.2023.03.008_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.6004\/jnccn.2018.7111","article-title":"A\u00a0\u200bpopulation-based study of morbidity after pancreatic cancer diagnosis","volume":"17","author":"Sarkar","year":"2019","journal-title":"J\u00a0\u200bNatl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.ajt.2023.03.008_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12885-021-07790-z","article-title":"Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study","volume":"21","author":"Beachler","year":"2021","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.ajt.2023.03.008_bib17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ajt.2023.03.008_bib18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.ajkd.2011.07.015","article-title":"Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses","volume":"58","author":"Kasiske","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.ajt.2023.03.008_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/TP.0b013e3182200e8a","article-title":"Racial variation in the development of posttransplant lymphoproliferative disorders after renal transplantation","volume":"92","author":"Nee","year":"2011","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.ajt.2023.03.008_bib20","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/lt.26034","article-title":"Post-transplant lymphoproliferative disorders after liver transplantation: A retrospective cohort study including 1954 transplants","volume":"27","author":"Tajima","year":"2021","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.ajt.2023.03.008_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13666","article-title":"Epstein-Barr viral load monitoring for diagnosing post-transplant lymphoproliferative disorder in pediatric liver transplant recipients","volume":"24","author":"Seo","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2023.03.008_bib22","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3390\/cancers13040899","article-title":"Analysis of post-transplant lymphoproliferative disorder (PTLD) outcomes with Epstein-Barr virus (EBV) assessments-a single tertiary referral center experience and review of literature","volume":"13","author":"Lau","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"12","key":"10.1016\/j.ajt.2023.03.008_bib23","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1111\/ajt.15513","article-title":"The use of induction therapy in liver transplantation is highly variable and is associated with posttransplant outcomes","volume":"19","author":"Bittermann","year":"2019","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2023.03.008_bib24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/lt.24677","article-title":"Immunosuppression in pediatric liver transplant recipients: unique aspects","volume":"23","author":"Miloh","year":"2017","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.ajt.2023.03.008_bib25","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/j.1600-6143.2006.01406.x","article-title":"Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression","volume":"6","author":"Spada","year":"2006","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2023.03.008_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/lt.21397","article-title":"Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: clinical and pharmacoeconomic study in 50 children","volume":"14","author":"Gras","year":"2008","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.ajt.2023.03.008_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13723","article-title":"Induction regimens and post-transplantation lymphoproliferative disorder after pediatric intestinal transplantation: single-center experience","volume":"24","author":"Devine","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2023.03.008_bib28","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.TP.0000056635.59888.EF","article-title":"A\u00a0\u200bthree-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients","volume":"75","author":"Charpentier","year":"2003","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ajt.2023.03.008_bib29","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/00007890-200109270-00012","article-title":"Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression","volume":"72","author":"Mourad","year":"2001","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ajt.2023.03.008_bib30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V133769","article-title":"Association of antibody induction with short- and long-term cause-specific mortality in renal transplant recipients","volume":"13","author":"Meier-Kriesche","year":"2002","journal-title":"J\u00a0\u200bAm Soc Nephrol"},{"issue":"17-18","key":"10.1016\/j.ajt.2023.03.008_bib31","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0161-5890(03)00072-5","article-title":"Comparison of daclizumab, an interleukin 2 receptor antibody, to anti-thymocyte globulin-Fresenius induction therapy in kidney transplantation","volume":"39","author":"Abou-Jaoude","year":"2003","journal-title":"Mol Immunol"},{"issue":"6","key":"10.1016\/j.ajt.2023.03.008_bib32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1399-3046.2005.00371.x","article-title":"Long-term results of basiliximab induction immunosuppression in pediatric liver transplant recipients","volume":"9","author":"Ganschow","year":"2005","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2023.03.008_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14199","article-title":"EBV, CMV, and BK viral infections in pediatric kidney transplantation: frequency, risk factors, treatment, and outcomes","volume":"26","author":"Levi","year":"2022","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2023.03.008_bib34","article-title":"Comparison of basiliximab and anti-thymocyte globulin as induction therapy in pediatric heart transplantation: A survival analysis","volume":"5","author":"Ansari","year":"2015","journal-title":"J\u00a0\u200bAm Heart Assoc"},{"issue":"10","key":"10.1016\/j.ajt.2023.03.008_bib35","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.healun.2015.04.001","article-title":"Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab","volume":"34","author":"Ansari","year":"2015","journal-title":"J\u00a0\u200bHeart Lung Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2023.03.008_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13190","article-title":"Comparison of basiliximab vs antithymocyte globulin for induction in pediatric heart transplant recipients: an analysis of the International Society for Heart and Lung Transplantation database","volume":"22","author":"Butts","year":"2018","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2023.03.008_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/ajt.12962","article-title":"Differential rates of ischemic cholangiopathy and graft survival associated with induction therapy in DCD liver transplantation","volume":"15","author":"Halldorson","year":"2015","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2023.03.008_bib38","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/lt.20896","article-title":"Induction immunosuppression with rabbit antithymocyte globulin in pediatric liver transplantation","volume":"12","author":"Shah","year":"2006","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.ajt.2023.03.008_bib39","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/petr.12783","article-title":"Variation in resource utilization in liver transplantation at freestanding children\u2019s hospitals","volume":"20","author":"Minneman","year":"2016","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2023.03.008_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13605","article-title":"Society of pediatric liver transplantation: current registry status 2011-2018","volume":"24","author":"Elisofon","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2023.03.008_bib41","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cgh.2016.07.035","article-title":"Acute rejection increases risk of graft failure and death in recent liver transplant recipients","volume":"15","author":"Levitsky","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajt.2023.03.008_bib42","unstructured":"Children\u2019s Hospital. Association. Leverage Clinical and Resource Utilization Data. Accessed January 1, 2023. https:\/\/www.childrenshospitals.org\/content\/analytics\/product-program\/pediatric-health-information-system."},{"issue":"4","key":"10.1016\/j.ajt.2023.03.008_bib43","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/cncr.33974","article-title":"Late health outcomes after dexrazoxane treatment: A report from the Children\u2019s Oncology Group","volume":"128","author":"Chow","year":"2022","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ajt.2023.03.008_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cam4.1206","article-title":"Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232","volume":"7","author":"DiNofia","year":"2018","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.ajt.2023.03.008_bib45","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MLR.0b013e31824deff9","article-title":"Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children\u2019s hospitals with de novo acute lymphoblastic leukemia from health care administrative data","volume":"52","author":"Fisher","year":"2014","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.ajt.2023.03.008_bib46","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/pbc.24402","article-title":"Assembly of a cohort of children treated for acute myeloid leukemia at free-standing children\u2019s hospitals in the United States using an administrative database","volume":"60","author":"Kavcic","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.ajt.2023.03.008_bib47","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/pbc.24930","article-title":"Establishing a high-risk neuroblastoma cohort using the Pediatric Health Information System Database","volume":"61","author":"Desai","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.ajt.2023.03.008_bib48","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1097\/TP.0000000000004209","article-title":"Recipient and center factors associated with immunosuppression practice beyond the first year after liver transplantation and impact on outcomes","volume":"106","author":"Bittermann","year":"2022","journal-title":"Transplantation"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613523003519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613523003519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:38:55Z","timestamp":1761629935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613523003519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1600613523003519"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2023.03.008","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effectiveness and safety of antibody induction immunosuppression in a large cohort of United States pediatric liver transplant recipients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2023.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}